During the past decade, Iowa Cancer Specialists conducted 27 clinical trials. In the 10-year time frame, 27 clinical trials started and 4 clinical trials were completed, i.e. on
average, 14.8% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 4 clinical trials were completed. i.e. 44.4%
of trials that started reached the finish line.
Erlotinib Hydrochloride in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Completely Removed by Surgery (An ALCHEMIST Treatment Trial)
Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)
Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)
Doxorubicin Hydrochloride and Cyclophosphamide Followed by Paclitaxel With or Without Carboplatin in Treating Patients With Triple-Negative Breast Cancer
2015-07-01
2023-11-01
Recruiting
782
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Iowa Cancer Specialists" #1 sponsor was "National Cancer Institute (NCI)" with 12 trials, followed by "SWOG Cancer Research Network" with 8 trials
sponsored, "Alliance for Clinical Trials in Oncology" with 7 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 3 trials sponsored and "NRG Oncology"
with 3 trials sponsored. Other sponsors include -4 different institutions and
companies that sponsored additional 6 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Iowa Cancer Specialists"
#1 collaborator was "National Cancer Institute (NCI)" with 21 trials as a collaborator, "Canadian Cancer Trials Group" with 2 trials as a collaborator, "Bayer" with 1 trials as a collaborator, "Division of Cancer Control" with 1 trials as a collaborator and "NIH Biomarker, Imaging and Quality of Life Studies Funding Program (BIQSFP)" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 8 trials.
Clinical Trials Conditions at Iowa Cancer Specialists
According to Clinical.Site data, the most researched conditions in "Iowa Cancer Specialists" are
"Invasive Breast Carcinoma" (5 trials), "Stage IV Lung Cancer AJCC v8" (5 trials), "Stage IVA Lung Cancer AJCC v8" (5 trials), "Stage IVB Lung Cancer AJCC v8" (5 trials) and "Recurrent Lung Non-Small Cell Carcinoma" (4 trials). Many other conditions were trialed in "Iowa Cancer Specialists" in a lesser frequency.
Clinical Trials Intervention Types at Iowa Cancer Specialists
Most popular intervention types in "Iowa Cancer Specialists" are "Drug" (24 trials), "Other" (19 trials), "Biological" (11 trials), "Procedure" (11 trials) and "Radiation" (3 trials). Other intervention types were less common.
The name of intervention was led by "Biospecimen Collection" (8 trials), "Pembrolizumab" (7 trials), "Quality-of-Life Assessment" (7 trials), "Cisplatin" (6 trials) and "Computed Tomography" (6 trials). Other intervention names were less common.
Clinical Trials Genders at Iowa Cancer Specialists
The vast majority of trials in "Iowa Cancer Specialists" are
30 trials for "All" genders and 3 trials for "Female" genders.
Clinical Trials Status at Iowa Cancer Specialists
Currently, there are NaN active trials in "Iowa Cancer Specialists".
undefined are not yet recruiting,
12 are recruiting,
17 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in Iowa Cancer Specialists,
1 suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Iowa Cancer Specialists, 0 "Phase 1"
clinical trials were conducted, 12 "Phase 2" clinical
trials and 19 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 1 trials that are defined as “Not Applicable".